{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:44:04Z","timestamp":1791945844066,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejso.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T22:37:52Z","timestamp":1539729472000},"page":"625-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8806-2147","authenticated-orcid":false,"given":"Beatriz","family":"Febrero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Miguel","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Parrilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJM197308302890901","article-title":"C-cell hiperplasia preceding medullary thyroid carcinoma","volume":"289","author":"Wolfe","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejso.2007.03.020","article-title":"Neck management in medullary thyroid carcinoma","volume":"34","author":"Oskam","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.09.002_bib5","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/jc.2011-2534","article-title":"Biological relevance of medullary thyroid microcarcinoma","volume":"97","author":"Machens","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2018.09.002_bib6","first-page":"1017","article-title":"Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B","volume":"116","author":"O'Riordain","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJM199409293311302","article-title":"Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A","volume":"331","author":"Lips","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.09.002_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00000658-199409000-00002","article-title":"Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A","volume":"220","author":"Wells","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejso.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.surg.2010.09.020","article-title":"Do the recent American Thyorid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?","volume":"148","author":"Grubbs","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2018.09.002_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00268-013-2413-y","article-title":"Role of preoperative basal calcitonin levels in the timing of prophylactic thyroidectomy in patients with germline RET mutations","volume":"38","author":"Lifante","year":"2014","journal-title":"World J Surg"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ejso.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1756-6614-6-S1-S9","article-title":"Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers-the role of Ct serum level","volume":"6","author":"Jarzab","year":"2013","journal-title":"Thyroid Res"},{"key":"10.1016\/j.ejso.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0022-3468(76)90111-1","article-title":"Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children","volume":"11","author":"Leape","year":"1976","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/0022-3468(86)90037-0","article-title":"Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2","volume":"21","author":"Telander","year":"1986","journal-title":"J\u00a0Pediatr Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archsurg.1989.01410070099020","article-title":"Medullary carcinoma in children: results of early detection and surgery","volume":"124","author":"Telander","year":"1989","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American thyroid association guidelines task force on medullary thyroid carcinoma. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2018.09.002_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900463","article-title":"Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience","volume":"22","author":"Gimm","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib18","series-title":"AJCC cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.ejso.2018.09.002_bib19","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ejso.2018.09.002_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","article-title":"Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels","volume":"250","author":"Machens","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib21","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2002-021422","article-title":"RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome","volume":"88","author":"Pu\u00f1ales","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2018.09.002_bib22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa043999","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A","volume":"353","author":"Skinner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.09.002_bib23","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/COC.0b013e3182a78fec","article-title":"Early, prophylactic thyroidectomy in hereditary medullary thyroid carcinoma: a 26-year monoinstitutional experience","volume":"38","author":"Pelizzo","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejso.2018.09.002_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00268-009-0370-2","article-title":"Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study","volume":"34","author":"Schreinemakers","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1072-7515(02)01220-6","article-title":"Prophylactic thyroidectomy in MEN2A syndrome: experience in a single center","volume":"195","author":"Rodr\u00edguez","year":"2002","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1089\/thy.2007.0414","article-title":"Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A","volume":"18","author":"Pu\u00f1ales","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2018.09.002_bib27","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2010-1234","article-title":"Groupe Fran\u00e7ais des Tumeurs Endocrines. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais d'Etude des Tumeurs Endocrines","volume":"96","author":"Rohmer","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2018.09.002_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/eje.0.1440037","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study","volume":"144","author":"Nguyen","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2018.09.002_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2007.03153.x","article-title":"Familial prevalence and age of RET germline mutations: implications for screening","volume":"69","author":"Machens","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejso.2018.09.002_bib30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s12094-014-1172-z","article-title":"Genetic disorders of pediatric MEN2A patients in the south of Spain","volume":"16","author":"Martinez-Criado","year":"2014","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejso.2018.09.002_bib31","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"European Multiple Endocrine Neoplasia (EUROMEN) Study Group. Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.09.002_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/ejso.2002.1378","article-title":"Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a","volume":"29","author":"Kahraman","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.09.002_bib33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2005.15.531","article-title":"RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors","volume":"15","author":"Kouvaraki","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2018.09.002_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00423-013-1139-5","article-title":"Timing and extent thyroid surgery for gene carriers of hereditary C cell disease-a consensus statement of the European Society of Endocrine Surgeons (ESES)","volume":"399","author":"Niederle","year":"2014","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.ejso.2018.09.002_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2796.2004.01423.x","article-title":"Advances in the management of hereditary medullary thyroid cancer","volume":"257","author":"Machens","year":"2005","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ejso.2018.09.002_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejso.2018.09.002_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in Ret gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years' experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ejso.2018.09.002_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/eje.1.02216","article-title":"Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype","volume":"155","author":"Frank-Raue","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejso.2018.09.002_bib39","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/thy.2015.0673","article-title":"A\u00a0Nationwide study of Multiple Endocrine Neoplasia Type 2A in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma","volume":"26","author":"Opsahl","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.ejso.2018.09.002_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/thy.2009.0144","article-title":"Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer","volume":"19","author":"Machens","year":"2009","journal-title":"Thyroid"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318314203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318314203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:29:56Z","timestamp":1760059796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318314203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0748798318314203"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.09.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}